All posts by : Felistas

Grassroots rugby concussion guidelines need to be improved as players’ brains remain altered despite them being symptom-free and cleared to play, researchers have found.

Australian nurses have responded to hundreds of disaster events over the last six years, but new research led by Charles Darwin University (CDU) suggests they still aren’t ready for the impact of catastrophe. The work is published in the journal Health Emergency and Disaster Nursing.

In the early months of 2020, a curious thing happened. Around the globe, a new kind of number began appearing in government briefings and newspaper headlines. These weren’t just case counts or hospital admissions. They were predictions—curves plotted weeks into the future, graphs that told us when the COVID-19 wave would crest, how many ICU beds we’d need, and how soon we’d be safe again. The models had arrived.

There is a strong association between an older person’s view of how they are aging and how well they will physically recover after a fall.

People who have been taking antidepressants for more than two years are substantially more likely to experience withdrawal symptoms compared to short-term users when they come off the medication, finds a new study led by UCL researchers.

Scientists in the U.K., Australia and China have identified a brain molecule called NEAT1 that appears to play a central role in triggering light sensitivity (photophobia), a common and debilitating symptom of migraines. Their findings, published in The Journal of Headache and Pain, highlight how this molecule affects the brain’s pain response, contributing to the uncomfortable reaction to light that’s common during migraines.

Use of extracorporeal membrane oxygenation (ECMO) continues to rise, but this advanced form of life support is often not provided to patients equitably. Now, new research published at the ATS 2025 International Conference has confirmed that disadvantaged patients are less likely to receive ECMO, even though they live closer to hospitals that offer it.

The U.S. Food and Drug Administration has approved the humanized monoclonal antibody Zynyz (retifanlimab-dlwr) as the first first-line treatment for advanced anal cancer.

For patients with diffuse gliomas, tumor-related epilepsy (TRE) is not a strong prognostic factor, according to a study published in the May issue of Brain and Behavior.

There’s good news for people with migraine who take common drugs before or during pregnancy—a new study found no increase in neurodevelopmental disorders such as autism and ADHD in their children. The study, which looked at drugs used for migraine attacks called triptans, is published in Neurology.